Stockholm, November 22, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in IRRAS AB’s shares (short name: IRRAS) commenced today on Nasdaq First North Premier in Stockholm. IRRAS belongs to the healthcare sector and is the 98 th company to be admitted to trading on Nasdaq’s Nordic markets* in 2017.
IRRAS is a commercial-stage medical technology company focused on designing, developing and commercializing innovative solutions for various brain pathologies, with a goal of dramatically improving patient outcomes, reducing patient-time in the intensive care unit and medical ward, and providing significant health economic benefits to hospitals and healthcare providers.
The c ompany’s initial product focus is on intracranial fluid management solutions that utilize its proprietary platform technology, IRRA flow™ , which is a CE-marked, fully integrated, closed-circuit medical device system that enables intelligent intracranial fluid management as well as accurate, real-time monitoring of intracranial pressure. IRRAS maintains its headquarters in Stockholm, Sweden, with additional offices in Laichingen, Germany and La Jolla, California, USA. For more information, please visit www.irras.com .
“We welcome IRRAS to Nasdaq First North Premier,” said Adam Kostyál, SVP and Head of European listings at Nasdaq. “We continue to see a strong inflow of innovative healthcare sector companies leveraging Nasdaq First North as a platform for future growth, and we look forward to supporting IRRAS as on their journey as a public company.”
“We are pleased to list IRRAS shares on Nasdaq First North Premier,” said Kleanthis G. Xanthopoulos, Ph.D., President and CEO of IRRAS. “The capital raised during this initial public offering strengthens our financial infrastructure and enables IRRAS to rapidly advance our operational, clinical and commercial goals to become a leading medical technology company.”
IRRAS has appointed Wildeco Ekonomisk Information AB as the Certified Adviser.
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius .
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
| Media Relations Contact: Erik Granström +46 8 405 78 07 erik.granstrom@nasdaq.com |
